Xerostomia associated with didanosine
- 1 September 1992
- journal article
- letter
- Published by Elsevier in The Lancet
- Vol. 340 (8822) , 790
- https://doi.org/10.1016/0140-6736(92)92330-i
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Long-term toxicity/activity profile of 2',3'-dideoxyinosine in AIDS or AIDS-related complexThe Lancet, 1990
- Overview of Phase I Trials of 2′,3′-Dideoxyinosine (ddI) Conducted on Adult PatientsClinical Infectious Diseases, 1990
- The National Cancer Institute Phase I Study of 2′,3′-Dideoxyinosine Administration in Adults with AIDS or AIDS-Related Complex: Analysis of Activity and Toxicity ProfilesClinical Infectious Diseases, 1990
- Once-Daily Administration of 2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related ComplexNew England Journal of Medicine, 1990
- 2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related ComplexNew England Journal of Medicine, 1990